405174-45-0

Usage

Uses

Used in Scientific Research:
2-Bromo-3-(but-3-enyloxy)pyridine is used as a reagent in scientific research for the synthesis of complex compounds. Its unique chemical structure makes it a valuable component in the creation of new molecules with potential applications in various fields.
Used in Laboratory Settings:
In laboratory settings, 2-Bromo-3-(but-3-enyloxy)pyridine is used as a building block for the assembly of more complex molecules. Its reactive nature allows chemists to incorporate it into the synthesis process, leading to the development of new compounds with specific properties and functions.
Used in Pharmaceutical Industry:
2-Bromo-3-(but-3-enyloxy)pyridine is used as an intermediate in the synthesis of pharmaceutical compounds. Its role in creating complex molecules can contribute to the development of new drugs with improved therapeutic effects and reduced side effects.
Used in Chemical Synthesis:
2-Bromo-3-(but-3-enyloxy)pyridine is used as a key component in the synthesis of various chemical compounds. Its presence in the reaction can lead to the formation of new molecules with unique properties, which can be further utilized in different industries, such as materials science, agriculture, and environmental protection.

InChI:InChI=1/C9H10BrNO/c1-2-3-7-12-8-5-4-6-11-9(8)10/h2,4-6H,1,3,7H2

Upstream product

• 6602-32-0 2-bromo-pyridin-3-ol 
• 627-27-0 homoalylic alcohol 

Downstream Products

• 405174-46-1 4-methylene-3,4-dihydro-2H-pyrano[3,2-b]pyridine 
• 1561765-74-9 (S)-tert-butyl (4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)carbamate 
• 1561762-84-2 (S)-N-(4-(4-(trifluoromethyl)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)benzamide 
• 1561763-62-9 (S)-2-oxo-N-(4-(4-(trifluoromethyl)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-2,3-dihydrobenzo[d]oxazole-6-carboxamide 
• 1561764-85-9 (S)-N-(4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-5-hydroxypicolinamide 
• 1561765-43-2 (S)-1-(4-cyanophenyl)-3-(4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)urea 
• 1561777-94-3 4-(4-(trifluoromethyl)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-ol 
• 1561778-44-6 (S)-N-((S)-4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-2-methylpropane-2-sulfinamide 
• 1049634-21-0 Br^(1-)*C₃₅H₃₂N₂O₂P⁽¹⁺⁾ 
• 1049634-22-1 C₄₀H₃₄N₄O₂ 
• 1049634-23-2 C₃₈H₃₂N₄O 
• 1049634-20-9 C₁₇H₁₇BrN₂O₂ 
• 754149-09-2 C₈H₉NO₂ 
• 405174-47-2 4-hydroxymethyl-3,4-dihydro-2H-pyrano[3,2-b]pyridinyl-4-ol 

Relevant academic research and scientific papers

6,7-dihydro-5H-quinoline-8-hydrazone derivative iron chelator and application in preparation of antitumor drug

The invention provides a 6,7-dihydro-5H-quinoline-8-hydrazone derivative iron chelator and its application in the preparation of an antitumor drug. Specifically, the invention provides a compound as shown in the formula I, wherein each substituent is as defined in the specification. The compound of the invention can be used as an inhibitor of tumor cell proliferation for the preparation of an antitumor drug.

HETEROCYCLIC THIOSEMICARBAZONE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS

Pharmaceutical compounds, compositions, and methods are presented in which various heterocyclic thiosemicarbazone derivatives are prepared. Contemplated compounds will be suitable to inhibit or reduce cellular growth or proliferation and are thus beneficial in the manufacture of drugs to treat neoplastic diseases.

CHROMAN DERIVATIVES AS TRPM8 INHIBITORS

Chroman compounds and derivatives of Formula I are useful inhibitors of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.

FUNCTIONALLY SELECTIVE AZANITRILE ALPHA2C ADRENORECEPTOR AGONISTS

In its many embodiments, the present invention provides a novel class of azanitrile compounds as inhibitors of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, method

DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS

In its many embodiments, the present invention provides a novel class of chroman compounds of formula I as α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of prepaxing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.

Chemokine receptor binding heterocyclic compounds with enhanced efficacy

The invention relates to heterocyclic compounds consisting of a core nitrogen atom surrounded by three pendant groups, wherein two of the three pendant groups are preferably benzimidazolyl methyl and tetrahydroquinolyl, and the third pendant group contains N and optionally contains additional rings. The compounds bind to chemokine receptors, including CXCR4 and CCR5, and demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).